Predictors of response to first-generation somatostatin analogues
Parameters | Higher response | Lower response | Ref. |
---|---|---|---|
E-cadherin | ↑ | ↓ | [31] |
Ki67 | ↓ | ↑ | [38–40] |
Age | Older age | Younger age | [30, 41–44] |
Sex | Female | Male | [45–47] |
Baseline GH and IGF-1 | Moderately elevated levels | High levels | [45] |
T2 signal on MRI | Hypointensity | Hyperintensity | [37] |
Tumor volume and invasion | ↓ | ↑ | [41] |
Response to the short octreotide | Yes response (GH nadir < 3.5 ng/mL) | No response (GH nadir > 7 ng/mL) | [17] |
Cytokeratin distribution pattern | Perinuclear distribution (densely granular) | Distribution in droplet; fibrous bodies > 70% (sparsely granulated) | [38] |
SSTR-2 expression and SSTR-2/SSTR-5 ratio | ↑ | ↓ | [25] |
STTR: somatostatin receptor; AIP: aryl hydrocarbon receptor-interacting protein